There is growing awareness among all stakeholders involved in the food industry of the role that nutrition and lifestyle play in the onset of heart disease, diabetes, prostate cancer, breast cancer and obesity. These conditions account for 75% of all healthcare costs; in 2008, $2.1 trillion were spent in the U.S. on medical care, and 95 cents of every dollar was spent to treat disease after it had already occurred1.
Omega-9 oils, derived from Dow AgroSciences’ Nexera canola and sunflower seeds, represent the “next generation” of healthier oils2. With zero trans fat, a very low level of saturated fat (SFA) and more than 70% oleic acid (a monounsaturated fat, MUFA), the oils have the potential to reduce many common chronic diseases when substituted for higher SFA and trans fat products.